Generics 1

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Ataluren manufacturers

1 products found

Filters

1 products found

ataluren

Granules for oral suspension 125 mg, 250 mg, 1000 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Unavailable markets
Argentina , Brazil , Colombia , Mexico
Manufacturer #17629
This biopharmaceutical company specializes in developing transformative therapies for patients with rare diseases. Their focus is on addressing the root cause of these conditions, aiming to enhance the quality of life for those affected. Key therapeutic areas include metabolism disorders (such as familial chylomicronemia syndrome, familial partial lipodystrophy, and phenylketonuria) and neurology (covering diseases like amyotrophic lateral sclerosis, Duchenne muscular dystrophy, Friedreich ataxia, Huntington's disease, and spinal muscular atrophy). They operate globally with significant presence in regions like North America, the EU, and Asia. Their product portfolio encompasses prescription medications, leveraging cutting-edge technologies such as gene therapy and splicing modulation. The company is committed to rigorous research and development, evidenced by their ongoing clinical trials and pursuit of innovative treatment options. They hold GMP certifications and have secured patents for several of their products.

Manufacturer usually replies in 13 days

Want to see all 1 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation